Cilostazol
- Generic Name
- Cilostazol
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H27N5O2
- CAS Number
- 73963-72-1
- Unique Ingredient Identifier
- N7Z035406B
- Background
Cilostazol is a quinolinone derivative and antiplatelet agent with vasodilating properties that has been used in the symptomatic treatment of intermittent claudication in patients with peripheral ischaemia. It is marketed under the brand name Pletal by Otsuka Pharmaceutical Co.. Cilostazol works by inhibiting both primary and secondary aggregation and reduci...
- Indication
Indicated for the alleviation of symptoms of intermittent claudication (pain in the legs that occurs with walking and disappears with rest).
- Associated Conditions
- Intermittent Claudication
- Associated Therapies
- -
Efficacy Study of Cilostazol Loading in Elective Percutaneous Coronary Intervention
- Conditions
- Interventions
- First Posted Date
- 2009-07-14
- Last Posted Date
- 2009-07-21
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 400
- Registration Number
- NCT00938522
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism
- Conditions
- Interventions
- First Posted Date
- 2009-06-08
- Last Posted Date
- 2009-11-10
- Lead Sponsor
- Gyeongsang National University Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT00915733
- Locations
- 🇰🇷
Gyeongsang National University Hospital, Jinju, Korea, Republic of
Sufficient Treatment of Peripheral Intervention by Cilostazol
- First Posted Date
- 2009-06-03
- Last Posted Date
- 2010-07-22
- Lead Sponsor
- Kansai Rosai Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT00912756
- Locations
- 🇯🇵
Omihachiman Community Medical Center, Omihachiman city, Shiga, Japan
🇯🇵Department of Cardiology,Naganoken Koseiren Shinonoi, Nagano-city, Nagano, Japan
🇯🇵Kokura Memorial Hospital, Kitakyusy, Japan
Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) Polymorphism
- First Posted Date
- 2009-05-01
- Last Posted Date
- 2009-05-01
- Lead Sponsor
- Gyeongsang National University Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT00891670
- Locations
- 🇰🇷
Gyeong-Sang National University Hospital, Jinju, Gyeong-Nam, Korea, Republic of
Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events
- First Posted Date
- 2009-04-23
- Last Posted Date
- 2010-06-04
- Lead Sponsor
- Hanyang University
- Target Recruit Count
- 400
- Registration Number
- NCT00886574
- Locations
- 🇰🇷
Inha University Hospital, In Cheon, Korea, Republic of
🇰🇷Hallym University Hospital, Seoul, Korea, Republic of
🇰🇷Korea University Guro Hospital, Seoul, Korea, Republic of
Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions
- First Posted Date
- 2009-02-19
- Last Posted Date
- 2015-05-06
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT00847860
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
🇨🇳Shanghai Hua Shan Hospital, Shanghai, Shanghai, China
Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker
- Conditions
- Interventions
- First Posted Date
- 2009-01-16
- Last Posted Date
- 2010-04-22
- Lead Sponsor
- Otsuka Beijing Research Institute
- Target Recruit Count
- 200
- Registration Number
- NCT00823849
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, China
Evaluation of Cilostazol in Combination With L-Carnitine
- Conditions
- Interventions
- First Posted Date
- 2009-01-14
- Last Posted Date
- 2019-11-29
- Lead Sponsor
- Colorado Prevention Center
- Target Recruit Count
- 164
- Registration Number
- NCT00822172
- Locations
- 🇺🇸
HPV Heart, PA, Columbia, Maryland, United States
🇺🇸University of Massachusetts Medical Center, Worcester, Massachusetts, United States
🇺🇸Radiant Research, Inc, Columbus, Ohio, United States
The Efficacy of CILostazol ON Ischemic Complications After DES Implantation
- First Posted Date
- 2008-10-21
- Last Posted Date
- 2013-12-17
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 960
- Registration Number
- NCT00776828
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed Conditions
- First Posted Date
- 2008-10-16
- Last Posted Date
- 2011-09-09
- Lead Sponsor
- Otsuka Frankfurt Research Institute GmbH
- Target Recruit Count
- 44
- Registration Number
- NCT00773630
- Locations
- 🇩🇪
AAIPharma Deutschland GmbH & Co. KG, Neu-Ulm, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.